InvestorNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Spotlighted in Ascendiant Equity Analyst Report
IGC Pharma (NYSE American: IGC), a clinical-stage pharmaceutical company, is featured in a recent analyst coverage research report issued by Ascendiant Capital Markets LLC. The report included a “buy” recommendation with a $3 price target. The company noted that all reports prepared by analysts that spotlight IGC Pharma reflect the views of those analysts and are not necessarily those of IGC Pharma. “IGC is not responsible…